Court agrees with Ab­b­Vie’s method­ol­o­gy for dam­ages in Take­da case

Last year
Pharma
Law

Astel­las pulls law­suit over price ne­go­ti­a­tions as Xtan­di side­steps first list of 10 drugs

Last year
R&D

Janssen looks to turn PhI­II win for Ry­bre­vant in EGFR-mu­tat­ed NSCLC in­to pres­sure on As­traZeneca block­buster

Last year
R&D
Pharma

Mer­sana CEO to step down af­ter eight years; Roy­al­ty Phar­ma pays $150M for Skytro­fa roy­al­ties

Last year
News Briefing

How Bio­con Bi­o­log­ics is tak­ing on the US biosim­i­lars mar­ket

Last year
Pharma
Marketing

UK biotech brings in $226M Se­ries C

Last year
Financing

Bio­gen names Jane Gro­gan head of re­search af­ter split­ting R&D

Last year
People
R&D

Au­to-in­jectable drug mak­er Ak­ti­vax cuts 70 jobs, shuts two sites as it trims scale-up plans

Last year
People
Manufacturing

CSL Vi­for cut­ting 85 jobs in Cal­i­for­nia

Last year
People
Manufacturing

Kriya Ther­a­peu­tics buys sci­en­tif­ic ad­vi­sor’s NASH gene ther­a­py com­pa­ny

Last year
Deals
Pharma

No­var­tis re­cruits new ex-US leader from Ab­b­Vie as Marie-France Tschudin steps down

Last year
People

Schott Phar­ma plans Frank­furt Stock Ex­change list­ing by end of year to boost of­fer­ing to in­jectable drug com­pa­nies

Last year
Financing
Pharma

Nim­bus is back for more, rais­ing $210M to fu­el pipeline sev­en months af­ter $4B Take­da deal

Last year
Financing

Mod­er­na touts broad­er an­ti­body da­ta on up­dat­ed Covid vac­cine as it gears up for fall roll­out

Last year
R&D
Coronavirus

Amid aproci­ten­tan’s reg­u­la­to­ry re­view, Idor­sia is buy­ing back the hy­per­ten­sion drug from J&J in $350M deal

Last year
Deals
FDA+

Ex­clu­sive: Khosla Ven­tures leads seed round in mR­NA biotech look­ing to re­verse ag­ing by length­en­ing telom­eres

Last year
Financing
Startups

As­traZeneca’s Ul­tomiris la­bel ex­pan­sion stalls af­ter FDA re­jects sBLA, asks for REMS changes

Last year
FDA+

Il­lu­mi­na be­gan hunt for CEO can­di­dates in midst of ac­tivist fight, even­tu­al­ly pick­ing lit­tle-known di­ag­nos­tics ex­ec

Last year
People
Diagnostics

FDA ten­ta­tive­ly ap­proves gener­ic ver­sion of pe­di­atric HIV drug un­der PEP­FAR pro­gram

Last year
Pharma
FDA+

'F­DA is not a physi­cian,' ap­peals court rules in case against agen­cy's iver­mectin mes­sag­ing

Last year
Pharma
FDA+

Nestlé parts with peanut al­ler­gy treat­ment Pal­forzia

Last year
Deals
Pharma

Illi­nois col­lege of phar­ma­cy pe­ti­tions FDA to re­move clin­i­cal re­quire­ments for biosim­i­lars

Last year
FDA+

No­var­tis sues over IRA ahead of En­tresto price ne­go­ti­a­tions

Last year
Pharma
Law

Lung can­cer bio­mark­er cam­paign, launched with As­traZeneca, boosts its reach and adds phar­ma sup­port­ers

Last year
Pharma
Marketing
First page Previous page 285286287288289290291 Next page Last page
A service from the Financial Times